GlaxoSmithKline Acquires Orlistat Over-The-Counter Rights in the US
http://biz.yahoo.com/prnews/040719/nym093_1.html
Coverage nearing for obesity care
http://www.thnt.com/thnt/story/0,21282,1006911,00.html
Medicare Revises Stance on Obesity
"In the end, the firms best positioned to take advantage of Medicare's
policy change could be certain pharmaceutical outfits. Abbott
Laboratories' (NYSE: ABT), Johnson & Johnson's (NYSE: JNJ), and
Novartis' (NYSE: NVS) prescription drugs may not yet be covered by
Medicare, but these companies all dabble in the nutritional business."
http://www.fool.com/News/mft/2004/mft04071908.htm
There money to be made off of the public teat in obesity "treatments".
TC